One case study found that an infant with delayed development had slow gut motility along with other gastrointestinal symptoms, such as infrequent bowel movements, and was found to have low levels of carnitine
Phase Ib/II study of pembrolizumab and pegylated-interferon Alfa-2b in advanced melanoma
Enough to blunt therapeutic effect without triggering obvious side effects
Orforglipron is a next-generation oral GLP-1 agonist that could eventually make daily pills as effective as weekly injections
Some users report better results than they experienced with other providers of oral drops, potentially suggesting that formulation differences do matter
Figure 1 To elucidate these emerging insights, this review focuses specifically on hypothyroidism, rather than thyroid disorders in general, and synthesizes current knowledge on the mechanistic, clinical, and therapeutic implications of gut microbiota in this context